1. Home
  2. AREN vs FHTX Comparison

AREN vs FHTX Comparison

Compare AREN & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • FHTX
  • Stock Information
  • Founded
  • AREN 2016
  • FHTX 2015
  • Country
  • AREN United States
  • FHTX United States
  • Employees
  • AREN N/A
  • FHTX N/A
  • Industry
  • AREN Medical/Dental Instruments
  • FHTX Medicinal Chemicals and Botanical Products
  • Sector
  • AREN Health Care
  • FHTX Health Care
  • Exchange
  • AREN Nasdaq
  • FHTX Nasdaq
  • Market Cap
  • AREN 233.1M
  • FHTX 278.1M
  • IPO Year
  • AREN N/A
  • FHTX 2020
  • Fundamental
  • Price
  • AREN $4.93
  • FHTX $4.00
  • Analyst Decision
  • AREN Strong Buy
  • FHTX Strong Buy
  • Analyst Count
  • AREN 1
  • FHTX 5
  • Target Price
  • AREN $12.00
  • FHTX $11.80
  • AVG Volume (30 Days)
  • AREN 218.1K
  • FHTX 212.8K
  • Earning Date
  • AREN 11-13-2025
  • FHTX 10-31-2025
  • Dividend Yield
  • AREN N/A
  • FHTX N/A
  • EPS Growth
  • AREN N/A
  • FHTX N/A
  • EPS
  • AREN 2.74
  • FHTX N/A
  • Revenue
  • AREN $146,610,000.00
  • FHTX $24,173,000.00
  • Revenue This Year
  • AREN $29.48
  • FHTX $43.75
  • Revenue Next Year
  • AREN $11.72
  • FHTX $1.27
  • P/E Ratio
  • AREN $1.83
  • FHTX N/A
  • Revenue Growth
  • AREN 6.81
  • FHTX N/A
  • 52 Week Low
  • AREN $0.56
  • FHTX $2.95
  • 52 Week High
  • AREN $10.05
  • FHTX $9.70
  • Technical
  • Relative Strength Index (RSI)
  • AREN 45.85
  • FHTX 36.90
  • Support Level
  • AREN $4.19
  • FHTX $3.90
  • Resistance Level
  • AREN $5.10
  • FHTX $4.14
  • Average True Range (ATR)
  • AREN 0.37
  • FHTX 0.30
  • MACD
  • AREN 0.05
  • FHTX -0.02
  • Stochastic Oscillator
  • AREN 75.59
  • FHTX 30.26

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: